ASP015K
Showing 1 - 25 of 4,270
Pharmacokinetics of ASP015K, Healthy Volunteer Trial in Kyushu (peficitinib, Placebo)
Completed
- Pharmacokinetics of ASP015K
- Healthy Volunteer
- peficitinib
- Placebo
-
Kyushu, Japan(unnamed)
Sep 11, 2019
Rheumatoid Arthritis Trial in Japan (Peficitinib, Placebo, Methotrexate)
Rheumatoid Arthritis Trial in Japan, Korea, Republic of, Taiwan (Peficitinib, Placebo, Etanercept)
Patients With Impaired Renal Function Trial in Tokyo (ASP015K)
Completed
- Patients With Impaired Renal Function
- ASP015K
-
Tokyo, Japan
- +1 more
Apr 5, 2019
Patients With Impaired Hepatic Function Trial in Fukuoka, Kanagawa, Tokyo (ASP015K)
Completed
- Patients With Impaired Hepatic Function
- ASP015K
-
Fukuoka, Japan
- +5 more
Apr 5, 2019
Colitis, Ulcerative Trial in Worldwide (Placebo, JNJ-54781532 25 mg once daily, JNJ-54781532 75 mg once daily)
Completed
- Colitis, Ulcerative
- Placebo
- +4 more
-
La Jolla, California
- +101 more
Jan 3, 2019
NonSegmental Vitiligo Trial in Canada, United States (INCB054707, Placebo)
Active, not recruiting
- NonSegmental Vitiligo
- INCB054707
- Placebo
-
Hoover, Alabama
- +30 more
Nov 14, 2022
Myopia Trial in Worldwide (NVK-002 Concentration 1, NVK-002 Concentration 2, Placebo)
Active, not recruiting
- Myopia
- NVK-002 Concentration 1
- +2 more
-
Tucson, Arizona
- +25 more
Jan 3, 2023
Physical Inactivity Trial (Motor Skills Intervention)
Not yet recruiting
- Physical Inactivity
- Motor Skills Intervention
- (no location specified)
Apr 18, 2022
HIV Trial in Montpellier (20 ml blood test)
Not yet recruiting
- HIV Infections
- 20 ml blood test
-
Montpellier, Herault, FranceLa Colombiere Hospital
Feb 8, 2022
Hypertrophic Cardiomyopathy Trial in Madrid ("Symplicity Spyral" multi-electrode renal denervation catheter and "Symplicity G3"
Recruiting
- Hypertrophic Cardiomyopathy
- "Symplicity Spyral" multi-electrode renal denervation catheter and "Symplicity G3" generator (Renal Denervation System)
-
Madrid, SpainHospital Universitario 12 de Octubre
Nov 26, 2022
Evaluation in Clinical Practice of Urinary Disorders in Multiple
Not yet recruiting
- Multiple Sclerosis
- Urinary Bladder, Neurogenic
- Initial management of the urinary disorder/s identified during the screening phase
-
Vittoria, Ragusa, ItalyMultiple Sclerosis Center of ASP 7 Ragusa
Sep 29, 2021
Osteoarthritis Trial in India (Diclofenac Sodium Topical Gel, 1%, Voltaren Topical Gel, 1%, Vehicle Diclofenac Sodium Topical
Completed
- Osteoarthritis
- Diclofenac Sodium Topical Gel, 1%
- +2 more
-
Secunderabad, Andhra Pradesh, India
- +22 more
May 21, 2021